DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 124 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $214,561 | -83.9% | 16,868 | -82.1% | 0.00% | – |
| Q2 2023 | $1,329,461 | -8.6% | 94,422 | +0.3% | 0.00% | – |
| Q1 2023 | $1,453,907 | +30.7% | 94,104 | +38.6% | 0.00% | – |
| Q4 2022 | $1,112,471 | -82.6% | 67,875 | -80.3% | 0.00% | -100.0% |
| Q3 2022 | $6,387,000 | -26.2% | 345,249 | -47.5% | 0.00% | -33.3% |
| Q2 2022 | $8,649,000 | +1420.0% | 657,658 | +973.1% | 0.00% | – |
| Q1 2022 | $569,000 | +123.1% | 61,284 | +134.6% | 0.00% | – |
| Q4 2021 | $255,000 | -98.4% | 26,127 | -94.5% | 0.00% | -100.0% |
| Q3 2021 | $15,996,000 | +5.5% | 470,767 | +13.6% | 0.00% | 0.0% |
| Q2 2021 | $15,168,000 | -16.9% | 414,315 | +1.7% | 0.00% | -20.0% |
| Q1 2021 | $18,259,000 | -19.6% | 407,203 | +2.4% | 0.01% | -28.6% |
| Q4 2020 | $22,697,000 | +49.1% | 397,719 | +34.0% | 0.01% | +40.0% |
| Q3 2020 | $15,227,000 | -28.2% | 296,831 | -16.4% | 0.01% | -37.5% |
| Q2 2020 | $21,204,000 | +557.5% | 355,057 | +585.3% | 0.01% | +700.0% |
| Q4 2019 | $3,225,000 | +301.6% | 51,810 | +118.9% | 0.00% | – |
| Q3 2019 | $803,000 | -54.1% | 23,671 | -47.6% | 0.00% | -100.0% |
| Q3 2018 | $1,749,000 | – | 45,174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |